Stack
Analyzer

Choose the combination you use; See interaction & security auditing, function axis coverage and redundancy/gap notes on a single screen.

Substances in combination

Maximum 8 items. Your selection is saved in the link; you can share.

Interaction & security

  • medium riskAcetyl-L-Carnitine

    Asetil-L-Karnitin - dikkat

    In breast cancer patients receiving taxane chemotherapy, ALCAR did not prevent neuropathy and was associated with worse neuropathy in a randomized trial; the adverse difference persisted in long follow-up. Do not self-use it to prevent chemotherapy neuropathy; consult the oncology team.

Combination profile

Functional axis coverage

Cognitive ·1EnergysleepMoodneurotrophic

Source distribution

Yarı-sentetik ×1

These results are screening warnings. Severity describes a potential concern, not its probability or the certainty of clinical evidence. Some rules extrapolate from mechanisms or drug classes; an absent warning does not establish safety.

Looking for a new combination? Start from a goal with the Nootropic Finder or browse the ready-made stacks.

FDA: Mixing Medications and Dietary Supplements Can Endanger Your Health